Contacts

Dr. Gregor Schmid, LL.M. (Cambridge)

Associé

Read More

Dr. Niclas von Woedtke, MBA (Kellogg/ WHU)

Salary Partner

Read More

Dr. Jens Wolf

Associé

Read More

Philipp Hoegl

Salary Partner

Read More

Philipp Bergjans

Collaborateur

Read More

Dr. Stefanie Greifeneder

Partner

Read More

Dr. Andrea Sautter

Salary Partner

Read More

Sherin Sayed

Collaborateur

Read More

Nico Jänicke

Associé

Read More

Jan-Mathias Pfleging

Collaborateur senior

Read More

Thanos Rammos, LL.M.

Associé

Read More

Hazal Viola Koepp-Strand, LL.M. (Lund)

Collaborateur

Read More

Dr. Eva Surowiecki, LL.B. (London)

Collaborateur senior

Read More
Contacts

Dr. Gregor Schmid, LL.M. (Cambridge)

Associé

Read More

Dr. Niclas von Woedtke, MBA (Kellogg/ WHU)

Salary Partner

Read More

Dr. Jens Wolf

Associé

Read More

Philipp Hoegl

Salary Partner

Read More

Philipp Bergjans

Collaborateur

Read More

Dr. Stefanie Greifeneder

Partner

Read More

Dr. Andrea Sautter

Salary Partner

Read More

Sherin Sayed

Collaborateur

Read More

Nico Jänicke

Associé

Read More

Jan-Mathias Pfleging

Collaborateur senior

Read More

Thanos Rammos, LL.M.

Associé

Read More

Hazal Viola Koepp-Strand, LL.M. (Lund)

Collaborateur

Read More

Dr. Eva Surowiecki, LL.B. (London)

Collaborateur senior

Read More

27 février 2024

Bertelsmann Investments acquires pharma tech company EXTEDO with Taylor Wessing

Bertelsmann Investments acquires the pharmaceutical technology company EXTEDO for a double-digit million amount. A Taylor Wessing team led by the two partners Dr Gregor Schmid (Berlin) and Dr Niclas von Woedtke (Hamburg) advised Bertelsmann Investments on all legal issues in connection with the acquisition.

Bertelsmann Investments is the investment arm of Bertelsmann and has invested around €1.7 billion in over 400 innovative companies and funds to date. The venture capital company currently holds shares in more than 360 innovative companies and funds, particularly in the fields of education, digital media, fintech, e-commerce and adtech. The acquisition of EXTEDO expands Bertelsmann Investments' portfolio of companies with the aim of strategically expanding its position in the European growth market of pharma tech through synergies with existing portfolio companies. As a leading provider of software solutions and services in the field of regulatory information, EXTEDO brings extensive expertise to the table, which both industry customers and public authorities can draw on.

EXTEDO's customers include around 1,000 pharmaceutical companies and public institutions in more than 65 countries, including 35 regulatory authorities, which use the pharma tech service provider's solutions to optimise their regulatory business processes in the areas of document management, product registration, approval management and drug safety.

Legal advisors Bertelsmann Investments
Taylor Wessing Germany:
Jointly led by Dr Gregor Schmid (Partner, IP / IT / Data Law, Berlin) and Dr Niclas von Woedtke (Salary Partner, Corporate/M&A, Hamburg); Dr Jens Wolf (Partner), Philipp Hoegl (Salary Partner), Philipp Bergjans (Associate), all M&A/Venture Capital, all Hamburg; Dr Stefanie Greifeneder (Partner), Dr Andrea Sautter (Salary Partner), Sherin Sayed (Associate), all Patents Technology & Life Sciences, all Munich; Nico Jänicke (Partner), Jan-Mathias Pfleging (Senior Associate), Alois Lobkowicz (Associate), all Employment, Pensions & Mobility, all Berlin; Thanos Rammos (Partner), Hazal Viola Koepp-Strand (Associate), Dr. Eva Surowiecki, LL.B. (Associate), all IP/IT and Data Law, all Berlin

In-house Bertelsmann Investments: Dr Martin Dannhoff (lead)
Legal advisor to the seller: Dornbach RAe
 
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Fusions et acquisitions d’entreprises et marchés financiers internationaux

Healthcare & Life Sciences: Taylor Wessing advises Protembis GmbH on Series B financing round

27 mars 2024

par plusieurs auteurs

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Taylor Wessing advises Azenta Life Sciences on the acquisition of the Barkey Group

17 juin 2022

par plusieurs auteurs

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Taylor Wessing advises Formycon on acquisition of biosimilar assets in strategic partnership with ATHOS

31 mars 2022

par plusieurs auteurs

Cliquer ici pour en savoir plus